Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

FFP 104

Drug Profile

FFP 104

Alternative Names: FFP-104; FFP104-001

Latest Information Update: 08 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator FF Pharma
  • Class Anti-inflammatories; Monoclonal antibodies
  • Mechanism of Action CD40 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Crohn's disease; Primary biliary cirrhosis

Most Recent Events

  • 08 Oct 2021 No development reported - Phase-II for Crohn's disease in Netherlands, Belgium (IV)
  • 08 Oct 2021 No development reported - Phase-II for Primary biliary cirrhosis in Italy, United Kingdom, Netherlands (Parenteral)
  • 15 Feb 2019 FFP 104 is still in phase II trials for Crohn's disease and Primary biliary cirrhosis in Belgium, Italy, the Netherlands and United Kingdom (FF Pharma website, February 2019)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top